Health ❯ Healthcare ❯ Chronic Diseases

Chronic Kidney Disease

Type 2 Diabetes Kidney Function Treatment Efficacy Inflammation Treatment Approaches Risk Factors Patient Management Diagnosis and Treatment Treatment Innovations Hypertension Risk Assessment Machine Learning

Pacibekitug Cuts hs-CRP by Up to 89% in Phase II Kidney Disease Trial

Durable IL-6 suppression was achieved with infrequent dosing that needs confirmation of clinical benefit in larger phase III trials.

New Analyses Show Widespread Undiagnosed Kidney Disease and Sharp Rise in Women

Maze Therapeutics Reports Strong Phase 1 Signal for MZE782, Announces $150 Million Private Placement